{"id":389354,"date":"2020-11-30T07:03:38","date_gmt":"2020-11-30T12:03:38","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=389354"},"modified":"2020-11-30T07:03:38","modified_gmt":"2020-11-30T12:03:38","slug":"regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting\/","title":{"rendered":"Regeneron Announces Investor Webcast at American Society of Hematology 2020 Annual Meeting"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n TARRYTOWN, N.Y.<\/span>, Nov. 30, 2020<\/span> \/PRNewswire\/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will host\u00a0a webcast on\u00a0Monday,\u00a0December\u00a07, 2020 at 4:30pm EST<\/span>. Management will\u00a0discuss data presented at the American Society of Hematology (ASH) 2020 Annual\u00a0Meeting as well as provide updates on\u00a0the Company’s broader oncology and hematology portfolio.<\/p>\n

\n Conference Call Information<\/b>
\n
To access this call, dial (888) 660-6127 (U.S.) or (973) 890-8355 (International), conference ID 7442859.\u00a0 A link to the webcast may be accessed from the ‘Investors and Media’ page of Regeneron’s website at http:\/\/investor.regeneron.com\/events.cfm<\/a>. \u00a0A replay of the conference call and webcast will be archived on the Company’s website for at least 30 days.<\/p>\n

\n About<\/b>\u00a0Regeneron
<\/b>Regeneron\u00a0(NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to eight FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases and rare diseases.<\/p>\n

Regeneron is accelerating and improving the traditional drug development process through our proprietary\u00a0VelociSuite\u00ae<\/sup><\/i>\u00a0technologies, such as\u00a0VelocImmune\u00ae<\/sup><\/i>, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.<\/p>\n

For additional information about the company, please visit\u00a0www.regeneron.com<\/a>\u00a0or follow @Regeneron on Twitter.<\/p>\n

\n Contact Information:<\/b>
\n
Investor Relations
Justin Holko\u00a0
914.847.7786\u00a0
justin.holko@regeneron.com<\/a><\/p>\n

\n \"Cision\" View original content:http:\/\/www.prnewswire.com\/news-releases\/regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting-301181234.html<\/a><\/p>\n

SOURCE Regeneron Pharmaceuticals, Inc.<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire TARRYTOWN, N.Y., Nov. 30, 2020 \/PRNewswire\/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will host\u00a0a webcast on\u00a0Monday,\u00a0December\u00a07, 2020 at 4:30pm EST. Management will\u00a0discuss data presented at the American Society of Hematology (ASH) 2020 Annual\u00a0Meeting as well as provide updates on\u00a0the Company’s broader oncology and hematology portfolio. Conference Call Information To access this call, dial (888) 660-6127 (U.S.) or (973) 890-8355 (International), conference ID 7442859.\u00a0 A link to the webcast may be accessed from the ‘Investors and Media’ page of Regeneron’s website at http:\/\/investor.regeneron.com\/events.cfm. \u00a0A replay of the conference call and webcast will be archived on the Company’s website for at least 30 days. About\u00a0RegeneronRegeneron\u00a0(NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. … <\/p>\n

Continue reading “Regeneron Announces Investor Webcast at American Society of Hematology 2020 Annual Meeting”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-389354","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nRegeneron Announces Investor Webcast at American Society of Hematology 2020 Annual Meeting - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Regeneron Announces Investor Webcast at American Society of Hematology 2020 Annual Meeting - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire TARRYTOWN, N.Y., Nov. 30, 2020 \/PRNewswire\/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will host\u00a0a webcast on\u00a0Monday,\u00a0December\u00a07, 2020 at 4:30pm EST. Management will\u00a0discuss data presented at the American Society of Hematology (ASH) 2020 Annual\u00a0Meeting as well as provide updates on\u00a0the Company’s broader oncology and hematology portfolio. Conference Call Information To access this call, dial (888) 660-6127 (U.S.) or (973) 890-8355 (International), conference ID 7442859.\u00a0 A link to the webcast may be accessed from the ‘Investors and Media’ page of Regeneron’s website at http:\/\/investor.regeneron.com\/events.cfm. \u00a0A replay of the conference call and webcast will be archived on the Company’s website for at least 30 days. About\u00a0RegeneronRegeneron\u00a0(NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. … Continue reading "Regeneron Announces Investor Webcast at American Society of Hematology 2020 Annual Meeting"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-30T12:03:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY05335&sd=2020-11-30\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Regeneron Announces Investor Webcast at American Society of Hematology 2020 Annual Meeting\",\"datePublished\":\"2020-11-30T12:03:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting\\\/\"},\"wordCount\":300,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY05335&sd=2020-11-30\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting\\\/\",\"name\":\"Regeneron Announces Investor Webcast at American Society of Hematology 2020 Annual Meeting - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY05335&sd=2020-11-30\",\"datePublished\":\"2020-11-30T12:03:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY05335&sd=2020-11-30\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY05335&sd=2020-11-30\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Regeneron Announces Investor Webcast at American Society of Hematology 2020 Annual Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Regeneron Announces Investor Webcast at American Society of Hematology 2020 Annual Meeting - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting\/","og_locale":"en_US","og_type":"article","og_title":"Regeneron Announces Investor Webcast at American Society of Hematology 2020 Annual Meeting - Market Newsdesk","og_description":"PR Newswire TARRYTOWN, N.Y., Nov. 30, 2020 \/PRNewswire\/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will host\u00a0a webcast on\u00a0Monday,\u00a0December\u00a07, 2020 at 4:30pm EST. Management will\u00a0discuss data presented at the American Society of Hematology (ASH) 2020 Annual\u00a0Meeting as well as provide updates on\u00a0the Company’s broader oncology and hematology portfolio. Conference Call Information To access this call, dial (888) 660-6127 (U.S.) or (973) 890-8355 (International), conference ID 7442859.\u00a0 A link to the webcast may be accessed from the ‘Investors and Media’ page of Regeneron’s website at http:\/\/investor.regeneron.com\/events.cfm. \u00a0A replay of the conference call and webcast will be archived on the Company’s website for at least 30 days. About\u00a0RegeneronRegeneron\u00a0(NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. … Continue reading \"Regeneron Announces Investor Webcast at American Society of Hematology 2020 Annual Meeting\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-30T12:03:38+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY05335&sd=2020-11-30","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Regeneron Announces Investor Webcast at American Society of Hematology 2020 Annual Meeting","datePublished":"2020-11-30T12:03:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting\/"},"wordCount":300,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY05335&sd=2020-11-30","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting\/","name":"Regeneron Announces Investor Webcast at American Society of Hematology 2020 Annual Meeting - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY05335&sd=2020-11-30","datePublished":"2020-11-30T12:03:38+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY05335&sd=2020-11-30","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY05335&sd=2020-11-30"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-webcast-at-american-society-of-hematology-2020-annual-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Regeneron Announces Investor Webcast at American Society of Hematology 2020 Annual Meeting"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/389354","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=389354"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/389354\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=389354"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=389354"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=389354"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}